Natixis’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,921
Closed -$178K 1116
2025
Q3
$178K Hold
6,921
﹤0.01% 876
2025
Q2
$398K Hold
6,921
﹤0.01% 730
2025
Q1
$741K Buy
6,921
+6,920
+692,000% +$602K ﹤0.01% 613
2024
Q4
$44 Buy
+1
New +$60 ﹤0.01% 1025
2023
Q3
Sell
-9,336
Closed -$4.05M 973
2023
Q2
$4.05M Buy
+9,336
New +$5.25M 0.03% 314
2022
Q4
Sell
-1,336
Closed -$812K 1077
2022
Q3
$812K Sell
1,336
-8,268
-86% -$4.95M ﹤0.01% 804
2022
Q2
$5.24M Buy
+9,604
New +$4.86M 0.02% 432

Other funds holding AGL

Natixis's AGL Position: Q4 2025 in Review

Natixis sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 6,921 shares — an estimated $178K sold.

Natixis first reported a position in AGL in Q2 2022 and held it in 7 quarters. The position peaked at $5.24M in Q2 2022. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Natixis reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Natixis sold 6,921 Agilon Health shares in Q4 2025, an estimated $178K.
  • Natixis first reported a position in Agilon Health in Q2 2022 and held it in 7 quarters.
  • Natixis's Agilon Health position peaked at $5.24M in Q2 2022.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.